{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:15:07Z","timestamp":1774120507085,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.ccm.2012.03.005","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T22:18:20Z","timestamp":1335219500000},"page":"381-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antimicrobial Therapy for Bronchiectasis"],"prefix":"10.1016","volume":"33","author":[{"given":"Anne E.","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2012.03.005_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccm.2007.02.014","article-title":"Pathogenesis of bronchiectasis","volume":"28","author":"Morrissey","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib2","first-page":"6","article-title":"Inflammation: a two-edged sword: the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"10.1016\/j.ccm.2012.03.005_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib4","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1378\/chest.108.4.955","article-title":"Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort","volume":"108","author":"Nicotra","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"Pasteur","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09031936.05.00127704","article-title":"Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?","volume":"26","author":"Li","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.03.005_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.00163208","article-title":"Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.03.005_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/jac\/dkp007","article-title":"Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis","volume":"63","author":"Gillham","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccm.2012.03.005_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QCO.0b013e328336ead6","article-title":"Nontuberculous mycobacterial lung disease","volume":"23","author":"Griffith","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ccm.2012.03.005_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1440-1843.2009.01569.x","article-title":"Clinical challenges in managing bronchiectasis","volume":"14","author":"Tsang","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.ccm.2012.03.005_bib12","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2012.03.005_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1753465810366858","article-title":"New treatment options for bronchiectasis","volume":"4","author":"Metersky","year":"2010","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ccm.2012.03.005_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1378\/chest.08-0776","article-title":"Bronchiectasis","volume":"134","author":"O'Donnell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1183\/09031936.99.14512069","article-title":"A\u00a0comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbations of bronchiectasis","volume":"14","author":"Tsang","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.03.005_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/45.2.247","article-title":"Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis","volume":"45","author":"Darley","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccm.2012.03.005_bib17","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.00104209","article-title":"Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?","volume":"35","author":"Chang","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.03.005_bib19","first-page":"A176","article-title":"Radiographic evolution and antimicrobial resistance patterns in patients with bronchiectasis treated with cyclic antibiotics","volume":"2","author":"Biewend","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ccm.2012.03.005_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/34.1.149","article-title":"Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis","volume":"34","author":"Rayner","year":"1994","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccm.2012.03.005_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0954-6111(99)90090-2","article-title":"Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa","volume":"93","author":"Orriols","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib23","first-page":"1420","article-title":"A\u00a0pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis","volume":"127","author":"Scheinberg","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A\u00a0randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/thx.2008.112284","article-title":"Efficacy of nebulized colomycin in patients with non-cystic fibrosis bronchiectasis colonized with Pseudomonas aeruginosa","volume":"65","author":"Dhar","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2012.03.005_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1445-5994.2007.01404.x","article-title":"Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis","volume":"37","author":"Steinfort","year":"2007","journal-title":"Intern Med J"},{"key":"10.1016\/j.ccm.2012.03.005_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rmed.2011.11.018","article-title":"Outcomes of pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis","volume":"106","author":"White","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib28","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","article-title":"Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review","volume":"66","author":"Cai","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccm.2012.03.005_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Alberts","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low dose azithromycin in patients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.rmed.2011.01.009","article-title":"Long-term low dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","volume":"105","author":"Serisier","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease modifying effects of twice-weekly azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 55","key":"10.1016\/j.ccm.2012.03.005_bib34","first-page":"334S","article-title":"Randomized, placebo-controlled, double-blind, multi-center study to evaluate the safety and efficacy of ciprofloxacin dry powder for inhalation (ciprofloxacin DPI) compared with placebo in non-cystic fibrosis bronchiectasis","volume":"38","author":"Wilson","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.03.005_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1378\/chest.124.1.360","article-title":"Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers","volume":"124","author":"Newhouse","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib36","first-page":"A3191","article-title":"Effect of a 28-day course of two different doses of once a day liposomal ciprofloxacin for inhalation on sputum Pseudomonas aeruginosa density in non-CF bronchiectasis","volume":"181","author":"Bilton","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib37","first-page":"23S","article-title":"A placebo-controlled study of liposomal amikacin for inhalation once daily in the treatment of bronchiectasis patients with chronic Pseudomonas aeruginosa lung infection","volume":"34","author":"O'Donnell","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2012.03.005_bib38","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1164\/rccm.201008-1293OC","article-title":"Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa","volume":"183","author":"Geller","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2012.03.005_bib39","doi-asserted-by":"crossref","first-page":"512A","DOI":"10.1378\/chest.10522","article-title":"Microbiological results of a phase 2 open-label study of aztreonam for inhalation in patients with bronchiectasis and gram-negative bacteria in the airways","volume":"138","author":"Barker","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2012.03.005_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/dkp282","article-title":"Antibacterial activities of a fosfomycin\/tobramycin combination: a novel inhaled antibiotic for bronchiectasis","volume":"64","author":"MacLeod","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523112000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523112000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:47:09Z","timestamp":1759452429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523112000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0272523112000408"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2012.03.005","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial Therapy for Bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2012.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}